Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE is an experimental small molecule compound belonging to the class of alpha amino acid amides and phosphinic acid derivatives. Its structure features a phenyl group, a methoxy-carbonyl group, an alanyl moiety, and a hydroxyphosphinyl group connected to a 3-L-phenyllactate backbone[1][8]. The compound has been studied as a ligand in structural biology, notably in X-ray crystallography complexes with carboxypeptidase A[7]. It is not approved for clinical use and there are no known indications or marketed formulations. Its mechanism of action is presumed to involve inhibition of metalloenzymes such as carboxypeptidases by mimicking transition states or binding at the active site via its phosphinic acid moiety; however, specific pharmacological targets have not been definitively established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE.